InnoCare Pharma has been granted a patent for various crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. These forms exhibit specific X-ray diffraction peaks, with the most intense peak at 5.4°±0.2°. GlobalData’s report on InnoCare Pharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on InnoCare Pharma, Cancer treatment biomarkers was a key innovation area identified from patents. InnoCare Pharma's grant share as of April 2024 was 31%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for crystalline form of specific pharmaceutical compound
A recently granted patent (Publication Number: US11945792B2) discloses a series of crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide, each characterized by specific X-ray diffraction peaks. These forms exhibit distinct peak patterns at various degrees 2?, with the most intense peak varying across the different crystalline structures. For instance, one form shows peaks at 5.4°±0.2°, 8.4°±0.2°, 18.7°±0.2°, 19.1°±0.2°, 16.1°±0.2°, 21.9°±0.2°, and 10.1°±0.2° degrees 2?, with the most intense peak at 5.4±0.2 degrees 2?.
Moreover, the patent also includes a claim for a pharmaceutical composition containing any of the aforementioned crystalline forms along with a pharmaceutically acceptable carrier. This composition combines the unique crystalline structure of the active ingredient with a carrier that ensures its safe and effective delivery. By specifying the crystalline forms and their X-ray diffraction peaks, the patent provides a clear framework for the production and use of this compound in pharmaceutical applications, potentially leading to the development of novel medications with improved properties and efficacy.
To know more about GlobalData’s detailed insights on InnoCare Pharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
